aq-13
Small moleculeexperimental
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 1999 (NCT00323375)
Timeline
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4297695 ↗
Also known as
- aq-13
- aq-13
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01614964 | Phase 2 | Aug 1, 2013 | Tulane University, University of the Sciences, Techniques and Technologies of Bamako |
| NCT00455494 | Phase 1 | Mar 1, 2007 | Centers for Disease Control and Prevention (CDC), Tulane University |
| NCT00323375 | Phase 1 | Aug 1, 1999 | National Institutes of Health (NIH), Tulane University |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Tulane University | Academic/Hospital | 3 | 3 | 2 | 1999 |
| Centers for Disease Control and Prevention (CDC) | Government | 1 | 0 | 1 | 2007 |
| National Institutes of Health (NIH) | Government | 1 | 0 | 1 | 1999 |
| University of the Sciences, Techniques and Technologies of Bamako | Academic/Hospital | 1 | 0 | 1 | 2013 |
4 organizations
Page 1 / 1